AMS - HM - Inpatient Challenges: Drug Interactions; Systolic and Diastolic Heart Failure; Anticoagulation (Download)

Sale!

$59.50


Topics and Objectives

Title: Hospital Medicine – Inpatient Challenges: Drug Interactions; Systolic and Diastolic Heart Failure; Anticoagulation

Faculty: Michael P. Goldfinger, M.D., F.A.C.P., Vandana Y. Bhide, M.D., F.A.C.P., F.A.A.P., A.B.I.H.M.

Original Release Date: July 1, 2018  Expiration Date: July 1, 2021

TOPIC 1: Drug Interactions and Side Effects. 

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Determine the most common mechanisms for drug interactions.
  2. Identify some of the most frequent culprit drugs such as Warfarin and Acetaminophen, AED’s, NSAIDs, and Statins.
  3. Counsel patients regarding some of the most frequent side-effects seen with commonly used medications.
  4. Employ The Joint Commission 2016 Ambulatory Care National Patient Safety Goals.

TOPIC 2: Systolic and Diastolic Heart Failure.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Appropriately manage decompensated heart failure in hospitalized patients.
  2. Assess the indications for positive inotropic agents and ultrafiltration in systolic heart failure.
  3. Distinguish the treatment of systolic versus diastolic heart failure, as per the 2013 ACCF/AHA Guidelines for heart failure management.

TOPIC 3: Outpatient Anticoagulation Issues.

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Manage outpatients on warfarin using current CHEST guidelines and The Joint Commission 2016 National Patient Safety Goals.
  2. Determine factors leading to alterations in the international normalized ratio (INR).
  3. Advise patients on the appropriate choice, duration, and intensity of anticoagulation in a variety of clinical scenarios.
  4. Develop a familiarity with the new oral anticoagulants.

StreamingINCLUDED
Total Cost: $

    Title: Hospital Medicine – Inpatient Challenges: Drug Interactions; Systolic and Diastolic Heart Failure; Anticoagulation

    Faculty: Michael P. Goldfinger, M.D., F.A.C.P., Vandana Y. Bhide, M.D., F.A.C.P., F.A.A.P., A.B.I.H.M.

    Original Release Date: July 1, 2018  Expiration Date: July 1, 2021

    TOPIC 1: Drug Interactions and Side Effects. 

    Upon completion of this session, the participant should be able to: GL, EBM, COMP

    1. Determine the most common mechanisms for drug interactions.
    2. Identify some of the most frequent culprit drugs such as Warfarin and Acetaminophen, AED’s, NSAIDs, and Statins.
    3. Counsel patients regarding some of the most frequent side-effects seen with commonly used medications.
    4. Employ The Joint Commission 2016 Ambulatory Care National Patient Safety Goals.

    TOPIC 2: Systolic and Diastolic Heart Failure.

    Upon completion of this session, the participant should be able to: EBM, GL, COMP

    1. Appropriately manage decompensated heart failure in hospitalized patients.
    2. Assess the indications for positive inotropic agents and ultrafiltration in systolic heart failure.
    3. Distinguish the treatment of systolic versus diastolic heart failure, as per the 2013 ACCF/AHA Guidelines for heart failure management.

    TOPIC 3: Outpatient Anticoagulation Issues.

    Upon completion of this session, the participant should be able to: GL, EBM, COMP

    1. Manage outpatients on warfarin using current CHEST guidelines and The Joint Commission 2016 National Patient Safety Goals.
    2. Determine factors leading to alterations in the international normalized ratio (INR).
    3. Advise patients on the appropriate choice, duration, and intensity of anticoagulation in a variety of clinical scenarios.
    4. Develop a familiarity with the new oral anticoagulants.
    When you add a gift card to your CME purchase from American Medical Seminars:
    • The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
    • This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.

    Related products